Chandra Prakash - Concepedia

Author

Chandra Prakash

Also Known As

C PRAKASH, C Prakash, C. H. Surya Prakash, C. PRAKASH, C. Prakash, Chandra PRAKASH, Chandra Prakash, Chiranth M Prakash, Clement Prakash, Dr. Clement Prakash

451

Publications

15.2K

Citations

H-Index

209

Concepts

All Affiliations

Pfizer (United States)Washington University in St. Louis Goethe University Frankfurt Emory University Biogen (United States)

About

Chandra Prakash is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	64	6.4K
2	Natural Sciences	11	11	408
3	Health Sciences	6	6	418
4	Engineering	2	2	48
5	Management	1	1	20

Chandra Prakash

112

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery Anna Frisch, Chandra Prakash, Dawn Smiley, Diabetes Care	2010	720
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid Barry J. Marshall, Leah J. Barrett, Chandra Prakash, Gastroenterology BiochemistryUrea Protects HelicobacterBacteriologyMicrobial PhysiologyAntibacterial Agent	1990	397
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans Martin E. Dowty, Jinyan Lin, Tim F. Ryder, Drug Metabolism and Disposition	2014	265
METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS Jie Ling, Kim A. Johnson, Zhuang Miao, Drug Metabolism and Disposition	2005	219
Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites Deepak Dalvie, R. Scott Obach, Ping Kang, Chemical Research in Toxicology Circulating MetabolitesMetabolomic ProfilingSecondary MetaboliteMetabolic ModelVitro Systems	2009	183
Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease Chandra Prakash, Ray E. Clouse Clinical Gastroenterology and Hepatology Diagnostic DeviceRemote Patient MonitoringDiagnosisWireless Ph MonitoringPatient Monitoring	2005	171
Human radiolabeled mass balance studies: objectives, utilities and limitations Natalia A. Penner, Lewis J. Klunk, Chandra Prakash Biopharmaceutics & Drug Disposition New Drug CandidatesRadioactive ContaminationMetabolomic ProfilingBody CompositionBioanalysis	2009	152
Cholecalciferol (Vitamin D3) Therapy and Vitamin D Insufficiency in Patients with Chronic Kidney Disease: A Randomized Controlled Pilot Study Chandra Prakash, José Binongo, Thomas R. Ziegler, Endocrine Practice Renal FunctionRenal DiseaseVitamin D InsufficiencyVitamin D3Kidney Failure	2008	142

Page 1